Subscribe Sign In Register

Biomarin Pharmaceutical

Martin Shkreli, Chief Investment Officer of MSMB Capital Management
Portfolio
Pharmaceutical Companies Gird for Drug-Price Reckoning
Kaitlin Ugolik
October 8, 2015
tourbillon-thumbnail.jpg
Premium
Tourbillon Thrives on a Heady Mix of PR and Performance
Stephen Taub
June 9, 2015